NeuroOne Medical receives notice of allowance for key patent from USPTO

NeuroOne Medical (NMTC) Technologies has received a notice of allowance for a key patent from the U.S. Patent and Trademark Office, USPTO titled, “Methods for Making Probe Devices and Related Devices”. The U.S. Patent Application 17/392,773 is strategic in nature and covers novel methods of making neural probe devices, including specific steps for the arrangement of probe components and deposition of electrode contact material. In addition to this allowed patent application, NeuroOne’s patent portfolio includes 17 issued and pending patents in the United States and internationally, covering a wide variety of thin-film electrode technologies. Among these include both neural and spinal cord electrodes with unique structures to optimize the functionality and minimize the profile of those electrodes.